Leprosy Treatment Market by Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), by Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) – Global Industry Analytics COVID-19 Business Impact, and Trends, 2020-2026

                                          
Abstract
                    
The report covers forecast and analysis for the Leprosy Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Leprosy Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Leprosy Treatment market on a global level. In order to give the users of this report a comprehensive view on the Leprosy Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Drug Class, Route of Administration, Distribution Channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Leprosy is a serious medical condition caused by the Mycobacterium leprae bacteria. Leprosy is often referred to as Hansen's disease. It affects the skin, upper respiratory tract mucosal surfaces, peripheral nerves and the eyes. Leprosy can happen in people of all ages, from babies to older people. Delayed leprosy diagnosis is likely to induce some medical complications such as muscle spasms, erectile dysfunction, organ failure, loss of vision and other abnormalities. Leprosy is better avoided by avoiding contact with sick and untreated individuals. Leprosy is a curable condition and various drugs for the treatment of leprosy are available on the market. Multidrug Therapy (MDT), which includes using a mixture of medications, is one of the therapies for leprosy. The World Health Organization, for the prevention of leprosy, suggests a mixture of rifampicin, clofazimine and dapsone.


Based on Drug Class, global Leprosy Treatment market is segmented into Antibacterial, Leprostatics, Antitubercular, Others.

The study provides a decisive view on the Leprosy Treatment market by segmenting the market based on Drug Class, Route of Administration, Distribution Channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2026. Based on Drug Class, the market is segmented into Antibacterial, Leprostatics, Antitubercular, and Others.

Based on Route of Administration, the market is segmented into Oral, Injectable, and Topical. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically speaking, Asia pacific dominated the Leprosy Treatment market. Large Leprosy Treatment patient pool, growing awareness and presence of key players has led to increased demand for Leprosy Treatment.

Increasing prevalence of skin diseases is accelerating the growth of the demand for Leprosy Treatment. In addition, Rising government initiatives and favorable reimbursement scenario drives the growth of the market for Leprosy Treatment. However, the high cost of drugs and lack of awareness among people is expected to hamper the growth of the market for Leprosy Treatment.

Key players within global Leprosy Treatment market include Pfizer Inc., Bristol-Myers Squibb and Company, Eli Lily and Company, Johnson & Johnson Services Inc., GlaxoSmithKline PLC, Bayer AG, Cadila Pharmaceuticals, Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals and Merck & Co., Inc and others.

The report segments global Leprosy Treatment market as follows:

Global Leprosy Treatment Market: Drug Class Segment Analysis

	Antibacterial
	Leprostatics
	Antitubercular
	Others

Global Leprosy Treatment Market: Route of Administration Segment Analysis

	Oral
	Injectable
	Topical

Global Leprosy Treatment Market: Distribution Channel Segment Analysis

	Hospital Pharmacies
	Retail Pharmacies
	Drug Stores
	Online Pharmacies

Global Leprosy Treatment Market: Regional Segment Analysis

	North America
	
		The U.S.
		Canada
	
	
	Europe
	
		France
		The UK
		Spain
		Germany
		Italy
		Rest of Europe
	
	
	Asia Pacific
	
		China
		Japan
		India
		South Korea
		Southeast Asia
		Rest of Asia Pacific
	
	
	Latin America
	
		Brazil
		Mexico
		Rest of Latin America
	
	
	Middle East & Africa
	
		GCC
		South Africa
		Rest of Middle East & Africa